nodes	percent_of_prediction	percent_of_DWPC	metapath
Moclobemide—CYP2C9—Capecitabine—colon cancer	0.198	0.444	CbGbCtD
Moclobemide—CYP1A2—Fluorouracil—colon cancer	0.13	0.292	CbGbCtD
Moclobemide—CYP2C9—Fluorouracil—colon cancer	0.117	0.263	CbGbCtD
Moclobemide—Sickness—Irinotecan—colon cancer	0.0257	0.0476	CcSEcCtD
Moclobemide—Bezafibrate—PPARG—colon cancer	0.012	0.811	CrCbGaD
Moclobemide—Proctalgia—Capecitabine—colon cancer	0.0102	0.0188	CcSEcCtD
Moclobemide—Heartburn—Fluorouracil—colon cancer	0.00994	0.0184	CcSEcCtD
Moclobemide—Dysarthria—Irinotecan—colon cancer	0.00755	0.014	CcSEcCtD
Moclobemide—Dysarthria—Fluorouracil—colon cancer	0.00723	0.0134	CcSEcCtD
Moclobemide—Appetite absent—Methotrexate—colon cancer	0.00715	0.0132	CcSEcCtD
Moclobemide—Metrorrhagia—Capecitabine—colon cancer	0.00669	0.0124	CcSEcCtD
Moclobemide—Urine output increased—Vincristine—colon cancer	0.00663	0.0123	CcSEcCtD
Moclobemide—Polyuria—Vincristine—colon cancer	0.00606	0.0112	CcSEcCtD
Moclobemide—Extrasystoles—Capecitabine—colon cancer	0.00568	0.0105	CcSEcCtD
Moclobemide—Disorientation—Fluorouracil—colon cancer	0.00555	0.0103	CcSEcCtD
Moclobemide—Visual disturbance—Irinotecan—colon cancer	0.00547	0.0101	CcSEcCtD
Moclobemide—Osteoarthritis—Irinotecan—colon cancer	0.00518	0.00959	CcSEcCtD
Moclobemide—Dysarthria—Capecitabine—colon cancer	0.00505	0.00934	CcSEcCtD
Moclobemide—Osteoarthritis—Fluorouracil—colon cancer	0.00496	0.00918	CcSEcCtD
Moclobemide—Irritability—Fluorouracil—colon cancer	0.00474	0.00876	CcSEcCtD
Moclobemide—Dry skin—Fluorouracil—colon cancer	0.00455	0.00841	CcSEcCtD
Moclobemide—Gingivitis—Methotrexate—colon cancer	0.00453	0.00838	CcSEcCtD
Moclobemide—Abdominal distension—Irinotecan—colon cancer	0.00451	0.00834	CcSEcCtD
Moclobemide—Angina pectoris—Irinotecan—colon cancer	0.00436	0.00807	CcSEcCtD
Moclobemide—Urine output increased—Capecitabine—colon cancer	0.00432	0.00799	CcSEcCtD
Moclobemide—Dysuria—Vincristine—colon cancer	0.0043	0.00795	CcSEcCtD
Moclobemide—Angina pectoris—Fluorouracil—colon cancer	0.00418	0.00773	CcSEcCtD
Moclobemide—Sleep disorder—Capecitabine—colon cancer	0.00401	0.00741	CcSEcCtD
Moclobemide—Stomatitis—Vincristine—colon cancer	0.004	0.00739	CcSEcCtD
Moclobemide—Polyuria—Capecitabine—colon cancer	0.00395	0.00731	CcSEcCtD
Moclobemide—Sweating—Vincristine—colon cancer	0.00393	0.00727	CcSEcCtD
Moclobemide—Stomatitis—Irinotecan—colon cancer	0.00389	0.0072	CcSEcCtD
Moclobemide—Sweating—Irinotecan—colon cancer	0.00383	0.00708	CcSEcCtD
Moclobemide—Hepatic enzyme increased—Methotrexate—colon cancer	0.00376	0.00696	CcSEcCtD
Moclobemide—Dysarthria—Methotrexate—colon cancer	0.00376	0.00696	CcSEcCtD
Moclobemide—Stomatitis—Fluorouracil—colon cancer	0.00373	0.0069	CcSEcCtD
Moclobemide—Conjunctivitis—Fluorouracil—colon cancer	0.00372	0.00688	CcSEcCtD
Moclobemide—Hot flush—Capecitabine—colon cancer	0.00371	0.00686	CcSEcCtD
Moclobemide—Menopausal symptoms—Capecitabine—colon cancer	0.00368	0.0068	CcSEcCtD
Moclobemide—Hallucination—Vincristine—colon cancer	0.00366	0.00677	CcSEcCtD
Moclobemide—Bradycardia—Irinotecan—colon cancer	0.00365	0.00675	CcSEcCtD
Moclobemide—Osteoarthritis—Capecitabine—colon cancer	0.00347	0.00642	CcSEcCtD
Moclobemide—Visual impairment—Irinotecan—colon cancer	0.00346	0.00639	CcSEcCtD
Moclobemide—Migraine—Capecitabine—colon cancer	0.00341	0.00631	CcSEcCtD
Moclobemide—Flushing—Irinotecan—colon cancer	0.00333	0.00615	CcSEcCtD
Moclobemide—Irritability—Capecitabine—colon cancer	0.00331	0.00612	CcSEcCtD
Moclobemide—Urine output increased—Methotrexate—colon cancer	0.00322	0.00595	CcSEcCtD
Moclobemide—Dry skin—Capecitabine—colon cancer	0.00318	0.00588	CcSEcCtD
Moclobemide—Flatulence—Irinotecan—colon cancer	0.00308	0.00569	CcSEcCtD
Moclobemide—Gastritis—Capecitabine—colon cancer	0.00307	0.00568	CcSEcCtD
Moclobemide—Abdominal distension—Capecitabine—colon cancer	0.00302	0.00558	CcSEcCtD
Moclobemide—Agitation—Vincristine—colon cancer	0.00295	0.00545	CcSEcCtD
Moclobemide—Polyuria—Methotrexate—colon cancer	0.00294	0.00544	CcSEcCtD
Moclobemide—Angina pectoris—Capecitabine—colon cancer	0.00292	0.0054	CcSEcCtD
Moclobemide—Ill-defined disorder—Irinotecan—colon cancer	0.0029	0.00536	CcSEcCtD
Moclobemide—Vision blurred—Fluorouracil—colon cancer	0.00282	0.00521	CcSEcCtD
Moclobemide—Malaise—Irinotecan—colon cancer	0.00281	0.00521	CcSEcCtD
Moclobemide—Dysuria—Capecitabine—colon cancer	0.0028	0.00518	CcSEcCtD
Moclobemide—Syncope—Irinotecan—colon cancer	0.0028	0.00518	CcSEcCtD
Moclobemide—Haloperidol—ABCB1—colon cancer	0.00278	0.189	CrCbGaD
Moclobemide—Hypertension—Vincristine—colon cancer	0.00277	0.00512	CcSEcCtD
Moclobemide—Loss of consciousness—Irinotecan—colon cancer	0.00274	0.00507	CcSEcCtD
Moclobemide—Myalgia—Vincristine—colon cancer	0.00273	0.00505	CcSEcCtD
Moclobemide—Visual disturbance—Methotrexate—colon cancer	0.00272	0.00504	CcSEcCtD
Moclobemide—Hypertension—Irinotecan—colon cancer	0.00269	0.00498	CcSEcCtD
Moclobemide—Discomfort—Irinotecan—colon cancer	0.00263	0.00486	CcSEcCtD
Moclobemide—Stomatitis—Capecitabine—colon cancer	0.00261	0.00482	CcSEcCtD
Moclobemide—Conjunctivitis—Capecitabine—colon cancer	0.0026	0.00481	CcSEcCtD
Moclobemide—Osteoarthritis—Methotrexate—colon cancer	0.00258	0.00478	CcSEcCtD
Moclobemide—Confusional state—Irinotecan—colon cancer	0.00257	0.00475	CcSEcCtD
Moclobemide—Myalgia—Fluorouracil—colon cancer	0.00254	0.00471	CcSEcCtD
Moclobemide—Chest pain—Fluorouracil—colon cancer	0.00254	0.00471	CcSEcCtD
Moclobemide—Hyperhidrosis—Vincristine—colon cancer	0.00253	0.00468	CcSEcCtD
Moclobemide—Discomfort—Fluorouracil—colon cancer	0.00251	0.00465	CcSEcCtD
Moclobemide—Shock—Irinotecan—colon cancer	0.00251	0.00464	CcSEcCtD
Moclobemide—Irritability—Methotrexate—colon cancer	0.00246	0.00456	CcSEcCtD
Moclobemide—Hyperhidrosis—Irinotecan—colon cancer	0.00246	0.00455	CcSEcCtD
Moclobemide—Confusional state—Fluorouracil—colon cancer	0.00246	0.00455	CcSEcCtD
Moclobemide—Hypotension—Vincristine—colon cancer	0.00244	0.00452	CcSEcCtD
Moclobemide—Bradycardia—Capecitabine—colon cancer	0.00244	0.00452	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Vincristine—colon cancer	0.00238	0.00441	CcSEcCtD
Moclobemide—Tachycardia—Fluorouracil—colon cancer	0.00238	0.0044	CcSEcCtD
Moclobemide—Hypotension—Irinotecan—colon cancer	0.00238	0.0044	CcSEcCtD
Moclobemide—Insomnia—Vincristine—colon cancer	0.00237	0.00438	CcSEcCtD
Moclobemide—Paraesthesia—Vincristine—colon cancer	0.00235	0.00434	CcSEcCtD
Moclobemide—Visual impairment—Capecitabine—colon cancer	0.00231	0.00428	CcSEcCtD
Moclobemide—Insomnia—Irinotecan—colon cancer	0.0023	0.00426	CcSEcCtD
Moclobemide—Paraesthesia—Irinotecan—colon cancer	0.00229	0.00423	CcSEcCtD
Moclobemide—Hypotension—Fluorouracil—colon cancer	0.00228	0.00422	CcSEcCtD
Moclobemide—Decreased appetite—Vincristine—colon cancer	0.00227	0.00421	CcSEcCtD
Moclobemide—Dyspnoea—Irinotecan—colon cancer	0.00227	0.0042	CcSEcCtD
Moclobemide—Somnolence—Irinotecan—colon cancer	0.00226	0.00419	CcSEcCtD
Moclobemide—Fatigue—Vincristine—colon cancer	0.00225	0.00417	CcSEcCtD
Moclobemide—Dyspepsia—Irinotecan—colon cancer	0.00224	0.00415	CcSEcCtD
Moclobemide—Tinnitus—Capecitabine—colon cancer	0.00224	0.00414	CcSEcCtD
Moclobemide—Constipation—Vincristine—colon cancer	0.00224	0.00414	CcSEcCtD
Moclobemide—Flushing—Capecitabine—colon cancer	0.00223	0.00412	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00222	0.00411	CcSEcCtD
Moclobemide—Decreased appetite—Irinotecan—colon cancer	0.00221	0.0041	CcSEcCtD
Moclobemide—Insomnia—Fluorouracil—colon cancer	0.00221	0.00408	CcSEcCtD
Moclobemide—Fatigue—Irinotecan—colon cancer	0.0022	0.00406	CcSEcCtD
Moclobemide—Paraesthesia—Fluorouracil—colon cancer	0.00219	0.00405	CcSEcCtD
Moclobemide—Constipation—Irinotecan—colon cancer	0.00218	0.00403	CcSEcCtD
Moclobemide—Dyspnoea—Fluorouracil—colon cancer	0.00217	0.00402	CcSEcCtD
Moclobemide—Somnolence—Fluorouracil—colon cancer	0.00217	0.00401	CcSEcCtD
Moclobemide—Dyspepsia—Fluorouracil—colon cancer	0.00215	0.00397	CcSEcCtD
Moclobemide—Gastrointestinal pain—Vincristine—colon cancer	0.00214	0.00396	CcSEcCtD
Moclobemide—Decreased appetite—Fluorouracil—colon cancer	0.00212	0.00392	CcSEcCtD
Moclobemide—Feeling abnormal—Irinotecan—colon cancer	0.0021	0.00388	CcSEcCtD
Moclobemide—Dysuria—Methotrexate—colon cancer	0.00209	0.00386	CcSEcCtD
Moclobemide—Gastrointestinal pain—Irinotecan—colon cancer	0.00208	0.00385	CcSEcCtD
Moclobemide—Abdominal pain—Vincristine—colon cancer	0.00207	0.00382	CcSEcCtD
Moclobemide—Flatulence—Capecitabine—colon cancer	0.00206	0.00381	CcSEcCtD
Moclobemide—Dysgeusia—Capecitabine—colon cancer	0.00205	0.00378	CcSEcCtD
Moclobemide—Abdominal pain—Irinotecan—colon cancer	0.00201	0.00372	CcSEcCtD
Moclobemide—Feeling abnormal—Fluorouracil—colon cancer	0.00201	0.00372	CcSEcCtD
Moclobemide—Drowsiness—Methotrexate—colon cancer	0.00199	0.00368	CcSEcCtD
Moclobemide—Vision blurred—Capecitabine—colon cancer	0.00197	0.00364	CcSEcCtD
Moclobemide—Tremor—Capecitabine—colon cancer	0.00196	0.00362	CcSEcCtD
Moclobemide—Stomatitis—Methotrexate—colon cancer	0.00194	0.00359	CcSEcCtD
Moclobemide—Ill-defined disorder—Capecitabine—colon cancer	0.00194	0.00358	CcSEcCtD
Moclobemide—Urticaria—Fluorouracil—colon cancer	0.00194	0.00358	CcSEcCtD
Moclobemide—Conjunctivitis—Methotrexate—colon cancer	0.00193	0.00358	CcSEcCtD
Moclobemide—Sweating—Methotrexate—colon cancer	0.00191	0.00353	CcSEcCtD
Moclobemide—Malaise—Capecitabine—colon cancer	0.00188	0.00348	CcSEcCtD
Moclobemide—Asthenia—Vincristine—colon cancer	0.00188	0.00347	CcSEcCtD
Moclobemide—Syncope—Capecitabine—colon cancer	0.00187	0.00346	CcSEcCtD
Moclobemide—Palpitations—Capecitabine—colon cancer	0.00185	0.00341	CcSEcCtD
Moclobemide—Loss of consciousness—Capecitabine—colon cancer	0.00184	0.0034	CcSEcCtD
Moclobemide—Asthenia—Irinotecan—colon cancer	0.00183	0.00338	CcSEcCtD
Moclobemide—Hypertension—Capecitabine—colon cancer	0.0018	0.00334	CcSEcCtD
Moclobemide—Diarrhoea—Vincristine—colon cancer	0.00179	0.00331	CcSEcCtD
Moclobemide—Myalgia—Capecitabine—colon cancer	0.00178	0.00329	CcSEcCtD
Moclobemide—Chest pain—Capecitabine—colon cancer	0.00178	0.00329	CcSEcCtD
Moclobemide—Anxiety—Capecitabine—colon cancer	0.00177	0.00328	CcSEcCtD
Moclobemide—Discomfort—Capecitabine—colon cancer	0.00176	0.00325	CcSEcCtD
Moclobemide—Diarrhoea—Irinotecan—colon cancer	0.00174	0.00322	CcSEcCtD
Moclobemide—Dry mouth—Capecitabine—colon cancer	0.00174	0.00322	CcSEcCtD
Moclobemide—Dizziness—Vincristine—colon cancer	0.00173	0.0032	CcSEcCtD
Moclobemide—Pruritus—Fluorouracil—colon cancer	0.00173	0.00319	CcSEcCtD
Moclobemide—Visual impairment—Methotrexate—colon cancer	0.00172	0.00318	CcSEcCtD
Moclobemide—Confusional state—Capecitabine—colon cancer	0.00172	0.00318	CcSEcCtD
Moclobemide—Dizziness—Irinotecan—colon cancer	0.00168	0.00312	CcSEcCtD
Moclobemide—Shock—Capecitabine—colon cancer	0.00168	0.0031	CcSEcCtD
Moclobemide—Diarrhoea—Fluorouracil—colon cancer	0.00167	0.00309	CcSEcCtD
Moclobemide—Tinnitus—Methotrexate—colon cancer	0.00167	0.00308	CcSEcCtD
Moclobemide—Tachycardia—Capecitabine—colon cancer	0.00166	0.00308	CcSEcCtD
Moclobemide—Vomiting—Vincristine—colon cancer	0.00166	0.00308	CcSEcCtD
Moclobemide—Rash—Vincristine—colon cancer	0.00165	0.00305	CcSEcCtD
Moclobemide—Hyperhidrosis—Capecitabine—colon cancer	0.00165	0.00305	CcSEcCtD
Moclobemide—Dermatitis—Vincristine—colon cancer	0.00165	0.00305	CcSEcCtD
Moclobemide—Headache—Vincristine—colon cancer	0.00164	0.00303	CcSEcCtD
Moclobemide—Vomiting—Irinotecan—colon cancer	0.00162	0.003	CcSEcCtD
Moclobemide—Dizziness—Fluorouracil—colon cancer	0.00161	0.00298	CcSEcCtD
Moclobemide—Rash—Irinotecan—colon cancer	0.00161	0.00297	CcSEcCtD
Moclobemide—Dermatitis—Irinotecan—colon cancer	0.0016	0.00297	CcSEcCtD
Moclobemide—Headache—Irinotecan—colon cancer	0.0016	0.00295	CcSEcCtD
Moclobemide—Hypotension—Capecitabine—colon cancer	0.00159	0.00295	CcSEcCtD
Moclobemide—Nausea—Vincristine—colon cancer	0.00155	0.00287	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00155	0.00287	CcSEcCtD
Moclobemide—Vomiting—Fluorouracil—colon cancer	0.00155	0.00287	CcSEcCtD
Moclobemide—Insomnia—Capecitabine—colon cancer	0.00154	0.00285	CcSEcCtD
Moclobemide—Rash—Fluorouracil—colon cancer	0.00154	0.00284	CcSEcCtD
Moclobemide—Dermatitis—Fluorouracil—colon cancer	0.00154	0.00284	CcSEcCtD
Moclobemide—Paraesthesia—Capecitabine—colon cancer	0.00153	0.00283	CcSEcCtD
Moclobemide—Headache—Fluorouracil—colon cancer	0.00153	0.00283	CcSEcCtD
Moclobemide—Dysgeusia—Methotrexate—colon cancer	0.00152	0.00282	CcSEcCtD
Moclobemide—Dyspnoea—Capecitabine—colon cancer	0.00152	0.00281	CcSEcCtD
Moclobemide—Nausea—Irinotecan—colon cancer	0.00151	0.0028	CcSEcCtD
Moclobemide—Dyspepsia—Capecitabine—colon cancer	0.0015	0.00278	CcSEcCtD
Moclobemide—Decreased appetite—Capecitabine—colon cancer	0.00148	0.00274	CcSEcCtD
Moclobemide—Fatigue—Capecitabine—colon cancer	0.00147	0.00272	CcSEcCtD
Moclobemide—Vision blurred—Methotrexate—colon cancer	0.00147	0.00271	CcSEcCtD
Moclobemide—Constipation—Capecitabine—colon cancer	0.00146	0.0027	CcSEcCtD
Moclobemide—Nausea—Fluorouracil—colon cancer	0.00145	0.00268	CcSEcCtD
Moclobemide—Ill-defined disorder—Methotrexate—colon cancer	0.00144	0.00267	CcSEcCtD
Moclobemide—Feeling abnormal—Capecitabine—colon cancer	0.0014	0.0026	CcSEcCtD
Moclobemide—Malaise—Methotrexate—colon cancer	0.0014	0.00259	CcSEcCtD
Moclobemide—Gastrointestinal pain—Capecitabine—colon cancer	0.00139	0.00258	CcSEcCtD
Moclobemide—Urticaria—Capecitabine—colon cancer	0.00135	0.0025	CcSEcCtD
Moclobemide—Abdominal pain—Capecitabine—colon cancer	0.00135	0.00249	CcSEcCtD
Moclobemide—Chest pain—Methotrexate—colon cancer	0.00132	0.00245	CcSEcCtD
Moclobemide—Myalgia—Methotrexate—colon cancer	0.00132	0.00245	CcSEcCtD
Moclobemide—Discomfort—Methotrexate—colon cancer	0.00131	0.00242	CcSEcCtD
Moclobemide—Confusional state—Methotrexate—colon cancer	0.00128	0.00237	CcSEcCtD
Moclobemide—Hyperhidrosis—Methotrexate—colon cancer	0.00123	0.00227	CcSEcCtD
Moclobemide—Asthenia—Capecitabine—colon cancer	0.00122	0.00226	CcSEcCtD
Moclobemide—Pruritus—Capecitabine—colon cancer	0.00121	0.00223	CcSEcCtD
Moclobemide—Hypotension—Methotrexate—colon cancer	0.00119	0.00219	CcSEcCtD
Moclobemide—Diarrhoea—Capecitabine—colon cancer	0.00117	0.00216	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Methotrexate—colon cancer	0.00116	0.00214	CcSEcCtD
Moclobemide—Insomnia—Methotrexate—colon cancer	0.00115	0.00212	CcSEcCtD
Moclobemide—Paraesthesia—Methotrexate—colon cancer	0.00114	0.00211	CcSEcCtD
Moclobemide—Dyspnoea—Methotrexate—colon cancer	0.00113	0.00209	CcSEcCtD
Moclobemide—Somnolence—Methotrexate—colon cancer	0.00113	0.00209	CcSEcCtD
Moclobemide—Dizziness—Capecitabine—colon cancer	0.00113	0.00209	CcSEcCtD
Moclobemide—Dyspepsia—Methotrexate—colon cancer	0.00112	0.00207	CcSEcCtD
Moclobemide—Decreased appetite—Methotrexate—colon cancer	0.0011	0.00204	CcSEcCtD
Moclobemide—Fatigue—Methotrexate—colon cancer	0.00109	0.00202	CcSEcCtD
Moclobemide—Vomiting—Capecitabine—colon cancer	0.00108	0.002	CcSEcCtD
Moclobemide—Rash—Capecitabine—colon cancer	0.00107	0.00199	CcSEcCtD
Moclobemide—Dermatitis—Capecitabine—colon cancer	0.00107	0.00199	CcSEcCtD
Moclobemide—Headache—Capecitabine—colon cancer	0.00107	0.00198	CcSEcCtD
Moclobemide—Feeling abnormal—Methotrexate—colon cancer	0.00105	0.00193	CcSEcCtD
Moclobemide—Gastrointestinal pain—Methotrexate—colon cancer	0.00104	0.00192	CcSEcCtD
Moclobemide—Nausea—Capecitabine—colon cancer	0.00101	0.00187	CcSEcCtD
Moclobemide—Urticaria—Methotrexate—colon cancer	0.00101	0.00186	CcSEcCtD
Moclobemide—Abdominal pain—Methotrexate—colon cancer	0.001	0.00186	CcSEcCtD
Moclobemide—Asthenia—Methotrexate—colon cancer	0.000911	0.00168	CcSEcCtD
Moclobemide—Pruritus—Methotrexate—colon cancer	0.000898	0.00166	CcSEcCtD
Moclobemide—Diarrhoea—Methotrexate—colon cancer	0.000868	0.00161	CcSEcCtD
Moclobemide—Dizziness—Methotrexate—colon cancer	0.000839	0.00155	CcSEcCtD
Moclobemide—Vomiting—Methotrexate—colon cancer	0.000807	0.00149	CcSEcCtD
Moclobemide—Rash—Methotrexate—colon cancer	0.0008	0.00148	CcSEcCtD
Moclobemide—Dermatitis—Methotrexate—colon cancer	0.000799	0.00148	CcSEcCtD
Moclobemide—Headache—Methotrexate—colon cancer	0.000795	0.00147	CcSEcCtD
Moclobemide—Nausea—Methotrexate—colon cancer	0.000754	0.00139	CcSEcCtD
